Real World Evidence - when impact matters

Real World Evidence (RWE) enables value-based healthcare. It provides you with strategic support throughout the entire lifespan of a medicine. With our solid expertise in RWE studies, we can offer you valuable information for successful market entry, developing new medicinal products and improving the treatment of patients. We have carried out several RWE studies in many therapeutic areas, such as diabetes, neuropathic pain, psoriasis and Parkinson’s disease.  Have a look at our RWE studies here and contact us to find the best solution for your needs.

Way to success: RWD + PRO = RWE

  • RWD (Real World Data):  We collect RWD from national registers (National Institute for Health and Welfare THL, Social Insurance Institution of Finland KELA, Statistics Finland, etc.), university hospital data lakes including various electronic medical records, and private healthcare providers.
  • PRO (Patient-Reported Outcome): Patient-reported outcomes play a key role in creating a reliable full picture of a patient’s medicinal treatment. PRO information is collected through Oriola’s Research Pharmacy Network (involving more than 180 pharmacies, with national coverage) and in collaboration with patient organisations and private healthcare providers.
  • RWE (Real World Evidence): By combining healthcare systems and patient perspectives in a unique and tailored manner, we produce real world evidence for better health.

All our activities are guided by a passion for building solutions that support people’s health and welfare.

Heli Salminen-Mankonen

Heli Salminen-Mankonen

Head of Data Driven Business and Research
Phone Icon + 358 40 7192945
Jennie Tjernström

Jennie Tjernström

Key Account Manager
Phone Icon +46 70 918 45 52
Päivi Väänänen

Päivi Väänänen

Account Director
Phone Icon +358 50 533 8559